Subtype
Spinal Cord Neoplasm
CI-CAN-00001540Explore in graph →
Non-malignant7 active trials1 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001540Explore in graph →
Clinical trials
54 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02851706 | Natural History of and Specimen Banking for People With Tumors of the Central Nervous System | completed | — | 1,214 | National Cancer Institute (NCI)NIH | 1 | Aug 28, 2026 | clinicaltrials |
| NCT04227717 | Studying a New Piece of Equipment That Can Help Plan Radiation Therapy of the Spine | completed | N/A | 9 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 18, 2025 | clinicaltrials |
| NCT03052738 | Medical Marijuana in the Pediatric Central Nervous System Tumor Population | completed | — | 19 | University of Colorado, DenverOTHER | 1 | Aug 29, 2024 | clinicaltrials |
| NCT02790294 |
Data updated 22 days agoSource updated Aug 28, 2026source: clinicaltrials
| completed |
| N/A |
| 8 |
| Case Comprehensive Cancer CenterOTHER |
| 1 |
| May 14, 2024 |
| clinicaltrials |
| NCT04219969 | FDG PET-MRI for the Diagnosis of Spinal Cord Lesions | completed | N/A | 11 | M.D. Anderson Cancer CenterOTHER | 1 | May 9, 2024 | clinicaltrials |
| NCT01236560 | Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma | completed | Phase 2 / Phase 3 | 101 | National Cancer Institute (NCI)NIH | 2 | Feb 20, 2024 | clinicaltrials |
| NCT05096468 | Esketamine Combined With Pregabalin on Acute Postoperative Pain in Patients Undergoing Resection of Spinal Neoplasms. | completed | Phase 2 / Phase 3 | 90 | Beijing Tiantan HospitalOTHER | 1 | Jul 6, 2023 | clinicaltrials |
| NCT00100802 | Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas | completed | Phase 2 | 118 | Children's Oncology GroupNETWORK | 1 | Feb 15, 2023 | clinicaltrials |
| NCT02085941 | Image-guided Cryoablation of Head, Neck and Spine Tumors | completed | N/A | 30 | Dana-Farber Cancer InstituteOTHER | 1 | Aug 15, 2022 | clinicaltrials |
| NCT04331431 | Outcomes of the Intradural Extramedullary Tumors Resection | completed | N/A | 24 | Sohag UniversityOTHER | 0 | Apr 2, 2020 | clinicaltrials |
| NCT00826241 | Dose-Dense Temozolomide + Lapatinib for Recurrent Ependymoma | completed | Phase 2 | 58 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 22, 2019 | clinicaltrials |
| NCT03050203 | Custom Pack in Spine Surgery(kit) | completed | N/A | 37 | Istituto Ortopedico RizzoliOTHER | 1 | Jan 28, 2019 | clinicaltrials |
| NCT02613390 | Safety Evaluation of Intra-Operative MRI-Based Guidance for Laser Ablation of Epidural Metastasis | completed | N/A | 11 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 10, 2019 | clinicaltrials |
| NCT00381797 | Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma | completed | Phase 2 | 97 | National Cancer Institute (NCI)NIH | 1 | Nov 28, 2017 | clinicaltrials |
| NCT00326664 | AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors | completed | Phase 1 | 55 | National Cancer Institute (NCI)NIH | 1 | Mar 7, 2016 | clinicaltrials |
| NCT02494622 | Alternative Treatment of Giant Spinal Schwannomas | completed | — | 18 | Gulsah KaraorenOTHER_GOV | 1 | Jul 10, 2015 | clinicaltrials |
| NCT00946335 | ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors | completed | Phase 1 | 31 | National Cancer Institute (NCI)NIH | 1 | Jul 9, 2014 | clinicaltrials |
| NCT01076530 | Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors | completed | Phase 1 | 27 | National Cancer Institute (NCI)NIH | 2 | May 3, 2013 | clinicaltrials |
| NCT00053963 | FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00363272 | Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00430872 | Development of the MDASI-Spine Tumor Module | completed | — | 128 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2012 | clinicaltrials |
| NCT00631670 | Stereotactic Body Radiation Therapy (SBRT) for Tumors Near the Spinal Cord | completed | N/A | 21 | University of FloridaOTHER | 1 | Feb 3, 2012 | clinicaltrials |
| NCT00001417 | Direct Injection of Alcohol for the Treatment of Spinal Tumors | completed | — | 30 | National Institute of Neurological Disorders and Stroke (NINDS)NIH | 1 | Mar 4, 2008 | clinicaltrials |